Back

Safety and effectiveness of tegoprazan in patients treated with dual antiplatelet therapy after drug-eluting stent implantation for acute myocardial infarction.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (4) Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Oh-Hyun Lee

Yongin Severance Hospital, Yongin (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Aspirin does not reduce cardiovascular risk in smokers across coronary calcium scores after coronary computed tomography angiography
Mr G. Winther (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy presenting with ACS - a systematic review and meta-analysis
Doctor B. Hakkeem (Kozhikode, IN)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents
Professor S. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes
thumbnail
Congress Session
Optimal antithrombotic regimen after percutaneous coronary intervention in stable coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources